David R. Snydman
- Epidemiology top 0.05%
- Infectious Diseases top 0.05%
- Clinical Biochemistry top 0.05%
- Oncology top 1%
- Public Health, Environmental and Occupational Health top 0.5%
- Co-authors
- Shira DoronBarbara G. WernerL. A. McDermottMatthew E. FalagasVictor L. YuIoana BicaN V JacobusArthur J. Morris
- Topics
- Cytomegalovirus and herpesvirus research (92 papers)Bacterial Identification and Susceptibility Testing (67 papers)Antimicrobial Resistance in Staphylococcus (48 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
David R. Snydman
343 papers receiving 16.7k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Epidemiology 9.2k
- Infectious Diseases 6.9k
- Clinical Biochemistry 2.3k
- Oncology 1.7k
- Public Health, Environmental and Occupational Health 1.7k
Countries citing papers authored by David R. Snydman
This map shows the geographic impact of David R. Snydman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Snydman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Snydman more than expected).
Fields of papers citing papers by David R. Snydman
This network shows the impact of papers produced by David R. Snydman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Snydman. The network helps show where David R. Snydman may publish in the future.
Co-authorship network of co-authors of David R. Snydman
This figure shows the co-authorship network connecting the top 25 collaborators of David R. Snydman. A scholar is included among the top collaborators of David R. Snydman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Snydman. David R. Snydman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 14 | |
| 7 | 12 | |
| 8 | 40 | |
| 9 | 107 | |
| 10 | 234 | |
| 11 | 0 | |
| 12 | 99 | |
| 13 | 164 | |
| 14 | 301 | |
| 15 | Mosby's color atlas and text of infectious diseases | 4 |
| 16 | 52 | |
| 17 | 49 | |
| 18 | Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. | 68 |
| 19 | A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. | 11 |
| 20 | Use of immune globulins in the prevention and treatment of infections. | 19 |
About David R. Snydman
David R. Snydman is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Transplantation, having authored 350 papers that have together received 17.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (92 papers), Bacterial Identification and Susceptibility Testing (67 papers) and Antimicrobial Resistance in Staphylococcus (48 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (897 citations), Infectious Diseases (6.9k citations) and Clinical Biochemistry (2.3k citations). David R. Snydman has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Shira Doron, Barbara G. Werner, L. A. McDermott, Matthew E. Falagas, Victor L. Yu, Ioana Bica, N V Jacobus, Arthur J. Morris, Allen C. Steere and Stephen E. Malawista. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.